Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function
ClinicalTrials.gov study NCT02392767. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain
ClinicalTrials.gov study NCT00313014. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Pers
ClinicalTrials.gov study NCT01152450. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris
ClinicalTrials.gov study NCT01915732. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
ClinicalTrials.gov study NCT01814670. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
ClinicalTrials.gov study NCT02425826. IPD Sharing: YES. Countries: 1. Publications: 3.
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
ClinicalTrials.gov study NCT03359850. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01711359. IPD Sharing: YES. Countries: 19. Publications: 10.
Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT02536508. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Fac
ClinicalTrials.gov study NCT04594213. IPD Sharing: NO. Countries: 1. Publications: 2.
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
ClinicalTrials.gov study NCT01232283. IPD Sharing: Not stated. Countries: 9. Publications: 2.
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT03120949. IPD Sharing: Not stated. Countries: 18. Publications: 0.
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02065622. IPD Sharing: YES. Countries: 20. Publications: 4.
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
ClinicalTrials.gov study NCT01482884. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD
ClinicalTrials.gov study NCT02268396. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
ClinicalTrials.gov study NCT01566773. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study in Participants With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT01107457. IPD Sharing: YES. Countries: 2. Publications: 3.
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
ClinicalTrials.gov study NCT05104892. IPD Sharing: YES. Countries: 13. Publications: 1.
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
ClinicalTrials.gov study NCT01283464. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
ClinicalTrials.gov study NCT00073021. IPD Sharing: Not stated. Countries: 3. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.